The Power List Personified: Getting to Know Kevin Kreutter
July 17, 2025
Learning more about the people behind the 2025 Power List.
4 min read
False
Advertisement
Drug Discovery
From Ancient Tombs to Cancer Therapy
By Stephanie Vine
July 16, 2025
Fungus linked to archeologists’ deaths shows early promise in leukemia.
2 min read
AbbVie’s Eleni Lagkadinou on the Future of Cancer
By Stephanie Vine
July 14, 2025
What comes next for cancer drug development? AbbVie’s Eleni Lagkadinou discusses precision, AI, and her hope for turning cancer into a more chronic, manageable condition.
11 min read
Adjuvanted Vaccines Associated with Lower Dementia Risk
By Stephanie Vine
July 8, 2025
More evidence is emerging that vaccines may contribute to a lower risk of dementia.
3 min read
This Week’s Biopharma News: FDA Urged to Back Abortion Pill Mifepristone
July 8, 2025
Our latest news roundup reports on a malaria medicine for babies, EMA plasma manufacturing recommendations, nanomedicine for bladder cancer treatment, and more
4 min read
Can a Spider Venom-Inspired Peptide Revolutionize Sexual Dysfunction Medicine?
July 7, 2025
Another Day Pharma tells us how a spider venom-derived topical peptide might be able to help those affected by erectile dysfunction and female sexual dysfunction.
11 min read
New Weight-Loss Drug Aims for Results Without Harsh GI Effects
July 2, 2025
A new dual agonist GLP-1 is showing weight loss without gastrointestinal side effects and appetite suppression. We speak with the company to learn more.
3 min read
The Biosimulation Generation
July 1, 2025
Since the FDA announced plans to phase out mandatory animal testing, in silico drug discovery and development platforms are emerging. Welcome to the age of biosimulation.
6 min read
Targeting the Untouchables: Covalent Peptides That Target Elusive Transcription Factors
June 27, 2025
Researchers have developed a new way to create covalent peptide inhibitors of transcription factors – proteins once considered “undruggable.”
8 min read
